Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endocrine Disorders of Female Reproductive System”

4,172 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,172 results

Testing effectiveness (Phase 2)Ended earlyNCT02452424
What this trial is testing

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Daiichi Sankyo 78
Not applicableLooking for participantsNCT03877796
What this trial is testing

Clinical Pre-screening Protocol for Ovarian Cancer

Who this might be right for
Ovarian Cancer
Allarity Therapeutics 60
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Testing effectiveness (Phase 2)UnknownNCT05170594
What this trial is testing

Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer

Who this might be right for
Ovarian Cancer
The Second Affiliated Hospital of Shandong First Medical University 60
Not applicableStudy completedNCT00005654
What this trial is testing

Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome

Who this might be right for
HyperinsulinismPolycystic Ovary Syndrome
National Center for Research Resources (NCRR) 88
Not applicableStudy completedNCT02831556
What this trial is testing

Point of Care 3D Ultrasound for Various Applications: A Pilot Study

Who this might be right for
AppendicitisEvidence of CholecystectomyGallstones+20 more
Duke University 174
Early research (Phase 1)Study completedNCT00496860
What this trial is testing

Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies

Who this might be right for
Progressive Metastatic Malignancies
Altor BioScience 26
Testing effectiveness (Phase 2)UnknownNCT04998760
What this trial is testing

Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH )

Who this might be right for
1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer
Qi Zhou 96
Testing effectiveness (Phase 2)Ended earlyNCT02978222
What this trial is testing

Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer

Who this might be right for
Platinum Sensitive Ovarian CancerOvarian Cancer
Marker Therapeutics, Inc. 120
Testing effectiveness (Phase 2)UnknownNCT05311579
What this trial is testing

Niraparib Plus Anlotinib for Recurrent Ovarian Cancer

Who this might be right for
Ovarian CarcinomaSurvival OutcomesAdverse Events+6 more
Lei Li 36
Testing effectiveness (Phase 2)Ended earlyNCT06478862
What this trial is testing

Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy

Who this might be right for
Cancer of OvaryPancreatic Ductal Adenocarcinoma
Lipomedix Pharmaceuticals Inc. 19
Not applicableNot Yet RecruitingNCT07153705
What this trial is testing

OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer

Who this might be right for
Ovarian Cancer
Beihua Kong 32
Not applicableStudy completedNCT04932070
What this trial is testing

Berberine and Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary SyndromeBerberine
Azienda di Servizi alla Persona di Pavia 12
Testing effectiveness (Phase 2)Study completedNCT00466986
What this trial is testing

Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Southeastern Gynecologic Oncology 40
Post-approval studies (Phase 4)Study completedNCT03187353
What this trial is testing

IMProving Executive Function Study

Who this might be right for
Cognitive ImpairmentRRSO
University of Pennsylvania 69
Not applicableLooking for participantsNCT05051722
What this trial is testing

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Who this might be right for
Endometrial CancerCervical CancerAtypical Endometrial Hyperplasia+3 more
Mayo Clinic 3,110
Not applicableStudy completedNCT03229122
What this trial is testing

Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA

Who this might be right for
Ovarian Cancer
AstraZeneca 446
Not applicableUnknownNCT04805853
What this trial is testing

Myocardial Pathological Changes in Patients of Type 2 Diabetes With or Without PCOS Using Cardiac Magnetic Resonance

Who this might be right for
Type2 DiabetesPolycystic Ovary Syndrome
RenJi Hospital 561
Not applicableStudy completedNCT04546373
What this trial is testing

Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Grupo Español de Investigación en Cáncer de Ovario 316
Not applicableUnknownNCT01425541
What this trial is testing

Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition

Who this might be right for
HyperandrogenemiaPolycystic Ovary Syndrome (PCOS)
University of Virginia 60
Load More Results